{"entity":{"id":"nct03290534","kind":"trial","name":"Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®","aka":[],"tldr":"A phase 2 trial of CivaSheet in advanced solid tumours, run by CivaTech Oncology, now recruiting.","summary":"Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet® is a phase 2 interventional study registered as NCT03290534 by CivaTech Oncology, with 40 participants planned, started 2019-03-13 and due to reach its primary completion in 2026-12. Interventions recorded: CivaSheet.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT03290534","url":"https://clinicaltrials.gov/study/NCT03290534"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["civatech-oncology"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT03290534","phase":"2","setting":"Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®","sponsor":"CivaTech Oncology","enrolled":40,"outcomes":[]},"route":"/trials/nct03290534/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"company":[{"id":"civatech-oncology","kind":"company","name":"CivaTech Oncology","route":"/companies/civatech-oncology/"}]}}